Masimo Corporation - Asset Resilience Ratio
Masimo Corporation (MASI) has an Asset Resilience Ratio of 6.44% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore MASI total assets for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2020)
This chart shows how Masimo Corporation's Asset Resilience Ratio has changed over time. See MASI net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Masimo Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MASI company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $169.00 Million | 6.44% |
| Total Liquid Assets | $169.00 Million | 6.44% |
Asset Resilience Insights
- Limited Liquidity: Masimo Corporation maintains only 6.44% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Masimo Corporation Industry Peers by Asset Resilience Ratio
Compare Masimo Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
Xvivo Perfusion AB
ST:XVIVO |
Medical Devices | 12.30% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236 |
Medical Devices | 25.01% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
PetVivo Holdings Inc
NASDAQ:PETV |
Medical Devices | 2.18% |
Annual Asset Resilience Ratio for Masimo Corporation (2009–2020)
The table below shows the annual Asset Resilience Ratio data for Masimo Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 0.00% | $0.00 | $1.71 Billion | -- |
| 2019-12-31 | 8.60% | $120.00 Million | $1.40 Billion | +8.59pp |
| 2017-12-31 | 0.00% | $33.00K | $905.44 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $820.52 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $601.74 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $565.01 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $438.66 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $374.66 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $366.10 Million | -- |
| 2010-12-31 | 0.00% | $0.00 | $310.24 Million | -- |
| 2009-12-31 | 15.99% | $56.99 Million | $356.35 Million | -- |
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more